Curated News
By: NewsRamp Editorial Staff
January 02, 2025
Securities Class Action Lawsuit Filed Against Applied Therapeutics, Inc. by Kessler Topaz Meltzer & Check, LLP
Discuss on Reddit
LinkedIn
TelegramTLDR
- Join the securities class action lawsuit against Applied Therapeutics to protect your investment and seek potential compensation.
- Investors who purchased Applied Therapeutics securities during January 3, 2024, to December 2, 2024, can file a lead plaintiff application by February 18, 2025.
- By holding Applied Therapeutics accountable for misconduct, investors contribute to a fairer financial market and ensure drug trial integrity for patient safety.
- Applied Therapeutics faces legal action for alleged drug trial misconduct, highlighting the importance of transparency and adherence to clinical protocols in the pharmaceutical industry.
Impact - Why it Matters
This news matters as it highlights potential misconduct by Applied Therapeutics, Inc. that could have financial repercussions for investors. The lawsuit underscores the importance of transparency and adherence to regulatory standards in the pharmaceutical industry, ultimately impacting the credibility and trustworthiness of companies in the market.
Summary
The law firm of Kessler Topaz Meltzer & Check, LLP has filed a securities class action lawsuit against Applied Therapeutics, Inc. on behalf of investors who purchased securities between January 3, 2024, and December 2, 2024. The lawsuit alleges that Applied Therapeutics failed to adhere to trial protocol and good clinical practices for its drug candidate, govorestat, posing a risk of FDA rejection.
Source Statement
This curated news summary relied on this press release disributed by NewMediaWire. Read the source press release here, Securities Class Action Lawsuit Filed Against Applied Therapeutics, Inc. by Kessler Topaz Meltzer & Check, LLP
